Cutaneous Oncology News

Combination cryosurgery and topical 5-fluorouracil may be a better treatment alternative to invasive procedures for patients with low-risk nonmelanoma skin cancer, according to a study.

The FDA approved multiple products for dermatologic indications this year.

AiViva Biopharma has completed a phase 1/2 trial of AIV001, a nonsurgical treatment for basal cell carcinoma, the company announced in a press release.

Adjuvant treatment with messenger RNA in combination with Keytruda produced meaningful improvement in patients with resected high-risk melanoma, according to findings from a phase 2b study.

Patients treated with phototherapy without psoralens do not experience higher incidence rates of skin cancer compared with the general population, according to a study.

Patients with certain autoimmune and inflammatory conditions may develop cutaneous squamous cell carcinoma at higher rates than immunocompetent patients, according to a study.

Histopathologic regression of melanoma may be associated with favorable outcomes in patients eligible for sentinel lymph node biopsy and those with irresectable melanoma receiving immune checkpoint inhibitor therapy, according to a study.

Patients diagnosed with melanoma as an adolescent or child were more likely to have a family history of melanoma or have undergone radiation therapy, according to a study.

A device using elastic-scattering spectroscopy and artificial intelligence may assist primary care physicians in the quick and accurate detection of skin cancer, according to a study.

Reflectance confocal microscopy may increase consistent and accurate melanoma diagnoses independently of clinical and dermoscopic features, according to a study.